Skip to main content
. Author manuscript; available in PMC: 2015 Feb 11.
Published in final edited form as: Am J Kidney Dis. 2011 Nov 9;59(1):152–159. doi: 10.1053/j.ajkd.2011.08.035

Table 1.

FGF23 disorders and other regulators in humans

Disease Involved genes
Hypophosphatemia Hypophosphatemia rickets Activating mutation of FGF23 ***
Inactivating mutation of PHEX ***
Inactivating mutation of DMP 1 ***
Inactivating mutation of ENPP1 ***
Inactivating mutation of Npt2c **
Activating translocation of Klotho * / **

With renal lithiasis and/or osteopenia and/or hypercalciuria Inactivating mutation of Npt2a **
Inactivating mutation of Npt2c **
Inactivating mutation of NHERF1

Mac Cune Albright / fibrous dysplasia of bone Overexpression of FGF23, GNAS ***

Tumor-induced osteomalacia Overexpression of FGF23, MEPE, FGF7 and/or FRP4 ***

Epidermal naevus syndrome FGF-R3 ***

Hyperphosphatemia Familial tumoral calcinosis Inactivating mutation of FGF23 **
Inactivating mutation of Klotho ***
Inactivating mutation of GALNT3 **

FGF: fibroblast growth factor

PHEX: phosphate-regulating gene with homologies to endopeptidases on the X chromosome

DMP1: Dentin matrix protein 1

ENPP1 : ecto-nucleotide pyrophosphatase / phosphodiesterase 1

Npt2a: type IIa sodium-phosphate cotransporter (SLC34A1)

Npt2c: type IIc sodium-phosphate cotransporter (SLC34A3)

MEPE: matrix extracellular phosphoglycoprotein

FRP4: frizzled related protein 4

FGF-R3: fibroblast growth factor receptor 3

GALNT3: UDP-N-acetyl-a-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3

*

with associated hyperparathyroidism

**

disease associated with a low FGF23 serum level

***

disease associated with a high FGF23 serum level